Terns Pharmaceuticals Banner Image

Terns Pharmaceuticals

  • Ticker TERN
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Terns Pharmaceuticals Logo Image
  • 11-50 Employees
  • Based in Foster City, California
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates to address serious diseases such as NASH, obesity and cancer. Terns’ pipeline includes four clinical stage development programs including a THR-β agonist, an allosteric BCR-ABL inhibitor, an FXR agonist, a VAP-1 inhibitor, andMore a preclinical small-molecule GLP-1 receptor agonist program.
Terns Pharmaceuticals

Most Recent Annual Report

Terns Pharmaceuticals
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Terns Pharmaceuticals Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!